- Home
- PTLO vs LENZ Comparison
PTLO vs LENZ Comparison
Compare PTLO & LENZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PTLO | LENZ |
|---|---|---|
| Founded | 1963 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Restaurants | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 326.3M | 155.5M |
| IPO Year | 2021 | 2021 |
Fundamental Metrics
Financial Performance| Metric | PTLO | LENZ |
|---|---|---|
| Price | $4.10 | $4.72 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 11 | 5 |
| Target Price | $8.06 | ★ $44.00 |
| AVG Volume (30 Days) | ★ 1.2M | 704.8K |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.09 | N/A |
| Revenue | ★ $732,066,000.00 | $19,088,000.00 |
| Revenue This Year | $9.02 | $50.42 |
| Revenue Next Year | $5.81 | $197.16 |
| P/E Ratio | $45.67 | ★ N/A |
| Revenue Growth | ★ 3.03 | N/A |
| 52 Week Low | $3.78 | $4.54 |
| 52 Week High | $6.83 | $50.19 |
Technical Indicators
Market Signals| Indicator | PTLO | LENZ |
|---|---|---|
| Relative Strength Index (RSI) | 36.81 | 41.55 |
| Support Level | $3.79 | $4.59 |
| Resistance Level | $4.49 | $6.18 |
| Average True Range (ATR) | 0.19 | 0.32 |
| MACD | -0.07 | 0.02 |
| Stochastic Oscillator | 6.64 | 12.44 |
Price Performance
Historical ComparisonAbout PTLO Portillo's Inc.
Portillos Inc serves the Chicago street food industry through high-energy and multichannel restaurants designed to ignite the senses and create memorable dining experiences. The company owns and operates fast-casual restaurants in the United States, along with two food production commissaries in Illinois. Its menu includes hot dogs, beef and sausage sandwiches, sandwiches and ribs, salads, burgers, chicken, sides and soup, and others.
About LENZ LENZ Therapeutics Inc.
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products. Its products VIZZ (aceclidine ophthalmic solution) 1.44% is a once-daily eye drop developed to restore clear near vision for up to 10 hours. VIZZ is powered by aceclidine, highlighted by its differentiated mechanism of action as a predominantly pupil-selective miotic that interacts with the iris, with minimal ciliary muscle stimulation.